In Treatment of Overactive bladder (OAB) symptoms Miranix Tablet ER helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine. It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
Caution is advised when consuming alcohol with Miranix Tablet ER. Please consult your doctor.
Miranix Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Miranix Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Miranix Tablet ER does not usually affect your ability to drive.
Miranix Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Miranix Tablet ER may be needed. Please consult your doctor.
Miranix Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Miranix Tablet ER may be needed. Please consult your doctor. Use of Miranix Tablet ER is not recommended in patients with severe liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Care Formulation Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alembic Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Future Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chemo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alembic Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Astellas Pharma Inc || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Koye Pharmaceuticals Pvt ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dr Reddy's Laboratories Ltd || ₹14.5/tablet (25% cheaper)